retatrutide glucagon Research Guide: What the Phase 2 Trial Data Reported (2026) Retatrutide: How the Triple Agonist

Comparing Mounjaro to Other GLP-1 Treatments When comparing Mounjaro to established GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) , dulaglutide (Trulicity) , and liraglutide (Victoza, Saxenda) , several key differences emerge

10.1016/j.bbrc.2014.07.116 [DOI] [PubMed] [Google Scholar] Kishi, T

Securing supply for these blockbusters has been high on the agenda for both Eli Lilly and fellow GLP-1 developers, including Novo Nordisk, which reported 2023 sales from its own diabetes and weight loss semuglatide products Ozempic and Wegovy of $13.7 billion and $4.5 billion, respectively

Which is what brings us to microdosing

The polyphenol-rich extracts from grapes and red oranges included in GLP-1 Support are also important in supporting both the microbiome and the collagen structures of the skin